Innate Pharma (IPHA) Return on Equity [ROE] (2021 - 2025)
Innate Pharma's Return on Equity [ROE] came in at -1465.50% for the quarter ended Jun 30, 2025, down 1250.25 percentage points from -215.25% a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Return on Equity [ROE] (2021 - 2025) Analysis & Trends
For the year ended Dec 31, 2024, Innate Pharma's Return on Equity [ROE] was -162.99%, down 148.52 percentage points from the prior year.
- Return on Equity [ROE] carries a five-year change of -151.73 percentage points (years ended Dec 2019 to Dec 2024).
- Going back by year, Return on Equity [ROE] was -14.47% in the year ended Dec 31, 2023 (+53.58 pp), -68.05% in the year ended Dec 31, 2022 (-27.91 pp), -40.14% in the year ended Dec 31, 2021 (-3.20 pp) and -36.94% in the year ended Dec 31, 2020 (-25.69 pp).
- The figure for the quarter ended Jun 30, 2025 represents the lowest quarterly Return on Equity [ROE] in data going back to the quarter ended Jun 30, 2021.
- Year-over-year, Return on Equity [ROE] increased in 1 of the last four quarters, with an average year-over-year change of -382.26 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Innate Pharma | 152.76 Mn | 152.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1,465.50% |
| Dec 31, 2024 | -430.45% |
| Jun 30, 2024 | -215.25% |
| Dec 31, 2023 | -112.55% |
| Jun 30, 2023 | -201.51% |
| Dec 31, 2022 | -165.38% |
| Jun 30, 2022 | -133.86% |
| Dec 31, 2021 | -124.51% |
| Jun 30, 2021 | -80.28% |
API Access
Innate Pharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();